News Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:31:30 06/03/2026 GMT			5-day change	1st Jan Change
123.26 ^CHF	-1.25%		-5.55%	+12.46%

03-06	Novartis Shareholders Approve Dividend Raise, Share Capital Reduction	MT
03-06	Novartis AG Approves Board and Committee Appointments	CI

All News

03-06	Novartis Shareholders Approve Dividend Raise, Share Capital Reduction	MT
03-06	Novartis AG Approves Board and Committee Appointments	CI
03-06	Novartis AG Approves Dividend for 2025, Payable from March 12, 2026	CI
03-06	Servier to buy Day One Biopharma for $2.5 billion in tumor treatment push	RE
03-06	Novartis Shareholders Re-elect Board Chair	MT
03-06	Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting	GL
03-06	Berenberg Raises Price Target on Novartis to $141 From $116, Keeps Hold Rating	MT
03-06	Novartis AG - Shareholder/Analyst Call
03-06	NOVARTIS AG : Berenberg remains Neutral	ZD
03-06	Swiss stocks - Factors to watch on March 6	RE
03-05	ETFs to counter market volatility
03-05	FTSE 100 to rise, Reckitt celebrates "strong year"	AN
03-04	Citius Oncology, Inc. Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR Dosing Prior to Commercial CAR-T Therapy in High-Risk Diffuse Large B-Cell Lymphoma	CI
03-02	Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy	AQ
02-27	Sector Update: Health Care Stocks Advance Late Afternoon	MT
02-27	Tariffs Influenced Novartis to Build Over 7 Plants in US, Trump Says	MT
02-27	Tariffs Influenced Novartis to Build Over 7 Plants in US, Trump Says	MT
02-27	Novartis AG completed the acquisition of Avidity Biosciences, Inc. from RTW Biotech Opportunities Ltd and others.	CI
02-27	European Stocks Mostly Higher in Friday Trading; French GDP Growth Slows, Inflation Rises	MT
02-27	Atrium Therapeutics Begins Operations With 2 Precision Cardiology Candidates	MT
02-27	Novartis Completes Acquisition of Avidity Biosciences	MT
02-27	Novartis Closes $12 Billion Acquisition of Avidity Biosciences	MT
02-27	Novartis Closes $12 Billion Acquisition of Avidity Biosciences	MT
02-27	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Inflation Data Release	MT
02-27	Novartis completes acquisition of Avidity Biosciences	RE